Somryst, A Prescription Digital Therapeutic for Chronic Insomnia, Gets FDA Nod
The FDA has approved Somryst™ (Pear Therapeutics), a prescription digital therapeutic (PDT) intended for the treatment of patients 22 years of age and older with chronic insomnia.